Skip to main content
Top
Published in: Archives of Virology 10/2009

01-10-2009 | Original Article

Comparison of the activities of BM2 protein and its H19 and W23 mutants of influenza B virus with activities of M2 protein and its H37 and W41 mutants of influenza A virus

Authors: Tatiana Betakova, Alan J. Hay

Published in: Archives of Virology | Issue 10/2009

Login to get access

Abstract

Co-expression of the BM2 protein with pH-sensitive HA reduces the conversion of HA to its low-pH conformation during transport to the cell surface in the same way as human M2 proteins. BM2 protein is capable of increasing vesicular pH by as much as 0.4 pH units. Mutation analysis showed that replacement of H19 in BM2 protein by A and L resulted in loss of activity, while M2, with the mutation H37A, remained active, but its severe toxicity was intolerable for cells. Whereas substitution of L or A for W23 abolished detectable activity of the BM2 channel, substitution of L for W41 in the M2 protein resulted in a functional ion channel but with reduced activity. W41 was not essential for functional activity of the M2 protein. Our results show some differences in the nature of the interaction of the histidine and tryptophan in the transmembrane domains of BM2 and M2 ion channels.
Literature
1.
go back to reference Balannik V, Lamb RA, Pinto LH (2008) The oligomeric state of the active BM2 ion channel protein of influenza B virus. J Biol Chem 283:4895–4904PubMedCrossRef Balannik V, Lamb RA, Pinto LH (2008) The oligomeric state of the active BM2 ion channel protein of influenza B virus. J Biol Chem 283:4895–4904PubMedCrossRef
2.
go back to reference Betakova T, Hay AJ (2009) Stability and function of the influenza A virus M2 ion channel protein is determined by both extracellular and cytoplasmic domains. Arch Virol 154:147–151PubMedCrossRef Betakova T, Hay AJ (2009) Stability and function of the influenza A virus M2 ion channel protein is determined by both extracellular and cytoplasmic domains. Arch Virol 154:147–151PubMedCrossRef
3.
go back to reference Betakova T, Kollerova E (2006) pH modulating activity of ion channels of influenza A, B, and C viruses. Acta Virol 50:187–193PubMed Betakova T, Kollerova E (2006) pH modulating activity of ion channels of influenza A, B, and C viruses. Acta Virol 50:187–193PubMed
4.
go back to reference Betakova T, Ciampor F, Hay AJ, Deakova E (2004) The tryptophan 41 is not essential for the function of the M2 proton channel of influenza A virus. In: Kawaoka Y (ed) Option for the Control of Influenza V, vol 1263C, 1st edn. Elsevier, BV, pp 777–780 Betakova T, Ciampor F, Hay AJ, Deakova E (2004) The tryptophan 41 is not essential for the function of the M2 proton channel of influenza A virus. In: Kawaoka Y (ed) Option for the Control of Influenza V, vol 1263C, 1st edn. Elsevier, BV, pp 777–780
5.
go back to reference Betakova T, Ciampor F, Hay AJ (2005) Influence of residue 44 on the activity of the M2 proton channel of influenza A virus. J Gen Virol 86:181–184PubMedCrossRef Betakova T, Ciampor F, Hay AJ (2005) Influence of residue 44 on the activity of the M2 proton channel of influenza A virus. J Gen Virol 86:181–184PubMedCrossRef
6.
go back to reference Chizhmakov IV, Geraghty FM, Ogden DC, Hayhurst A, Antoniou M, Hay AJ (1996) Selective proton permeability and pH regulation of the influenza virus M2 channel expressed in mouse erythroleukemia cells. J Physiol 494:329–336PubMed Chizhmakov IV, Geraghty FM, Ogden DC, Hayhurst A, Antoniou M, Hay AJ (1996) Selective proton permeability and pH regulation of the influenza virus M2 channel expressed in mouse erythroleukemia cells. J Physiol 494:329–336PubMed
7.
go back to reference Chizhmakov IV, Ogden DC, Geraghty FM, Hayhurst A, Skinner A, Betakova T, Hay AJ (2003) Differences in conductance of M2 proton channels of two influenza viruses at low and high pH. J Physiol 546:427–438PubMedCrossRef Chizhmakov IV, Ogden DC, Geraghty FM, Hayhurst A, Skinner A, Betakova T, Hay AJ (2003) Differences in conductance of M2 proton channels of two influenza viruses at low and high pH. J Physiol 546:427–438PubMedCrossRef
8.
go back to reference Ciampor F, Bayley PM, Nermut MV, Hirst EM, Sugrue RJ, Hay AJ (1992) Evidence that the amantadine-induced M2-mediated conversion of influenza A virus hemagglutinin to the low pH conformation occurs in an acidic trans-Golgi compartment. Virology 188:14–24PubMedCrossRef Ciampor F, Bayley PM, Nermut MV, Hirst EM, Sugrue RJ, Hay AJ (1992) Evidence that the amantadine-induced M2-mediated conversion of influenza A virus hemagglutinin to the low pH conformation occurs in an acidic trans-Golgi compartment. Virology 188:14–24PubMedCrossRef
9.
go back to reference Fuerst TR, Niles EG, Studier FW, Moss B (1986) Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc Natl Acad Sci USA 83:8122–8126PubMedCrossRef Fuerst TR, Niles EG, Studier FW, Moss B (1986) Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc Natl Acad Sci USA 83:8122–8126PubMedCrossRef
10.
go back to reference Grambas S, Hay AJ (1992) Maturation of influenza A virus hemagglutinin–estimates of the pH encountered during transport and its regulation by the M2 protein. Virology 190:11–18PubMedCrossRef Grambas S, Hay AJ (1992) Maturation of influenza A virus hemagglutinin–estimates of the pH encountered during transport and its regulation by the M2 protein. Virology 190:11–18PubMedCrossRef
11.
go back to reference Grambas S, Bennet MS, Hay AJ (1992) Influence of amantadine resistance mutations on the pH encountered during transport and its regulation by the M2 protein. Virology 191:541–549PubMedCrossRef Grambas S, Bennet MS, Hay AJ (1992) Influence of amantadine resistance mutations on the pH encountered during transport and its regulation by the M2 protein. Virology 191:541–549PubMedCrossRef
12.
go back to reference Hay AJ (1992) The action of adamantadines against influenza A viruses: inhibition of the M2 ion channel protein. Semin Virol 3:21–30 Hay AJ (1992) The action of adamantadines against influenza A viruses: inhibition of the M2 ion channel protein. Semin Virol 3:21–30
13.
go back to reference Hay AJ, Wolstenholme AJ, Skehel JJ, Smith MH (1985) The molecular basis of the specific anti-influenza action of amantadine. EMBO J 4:3021–3024PubMed Hay AJ, Wolstenholme AJ, Skehel JJ, Smith MH (1985) The molecular basis of the specific anti-influenza action of amantadine. EMBO J 4:3021–3024PubMed
15.
go back to reference Henkel JR, Popovich JL, Gibson GA, Watkins SC, Weisz OA (1999) Selective perturbation of early endosome and/or trans-Golgi network pH but not lysosome pH by dose-dependent expression of influenza M2 protein. J Biol Chem 274:9854–9860PubMedCrossRef Henkel JR, Popovich JL, Gibson GA, Watkins SC, Weisz OA (1999) Selective perturbation of early endosome and/or trans-Golgi network pH but not lysosome pH by dose-dependent expression of influenza M2 protein. J Biol Chem 274:9854–9860PubMedCrossRef
16.
go back to reference Holsinger LJ, Nichani D, Pinto LH, Lamb RA (1994) Influenza A virus M2 ion channel protein: a structure–function analysis. J Virol 68:1551–1563PubMed Holsinger LJ, Nichani D, Pinto LH, Lamb RA (1994) Influenza A virus M2 ion channel protein: a structure–function analysis. J Virol 68:1551–1563PubMed
17.
go back to reference Hu J, Fu R, Nishimura K, Zhang L, Zhou HX, Busath DD, Vijayvergiya V, Cross TA (2006) Histidines, heart of the hydrogen ion channel from influenza A virus: toward an understanding of conductance and proton selectivity. Proc Natl Acad Sci USA 103:6865–6870PubMedCrossRef Hu J, Fu R, Nishimura K, Zhang L, Zhou HX, Busath DD, Vijayvergiya V, Cross TA (2006) Histidines, heart of the hydrogen ion channel from influenza A virus: toward an understanding of conductance and proton selectivity. Proc Natl Acad Sci USA 103:6865–6870PubMedCrossRef
18.
go back to reference Imai M, Kawasaki K, Odagiri T (2008) Cytoplasmic domain of influenza B virus BM2 protein plays critical roles in production of infectious virus. J Virol 82:728–739PubMedCrossRef Imai M, Kawasaki K, Odagiri T (2008) Cytoplasmic domain of influenza B virus BM2 protein plays critical roles in production of infectious virus. J Virol 82:728–739PubMedCrossRef
19.
go back to reference Ma C, Soto CS, Ohigashi Y, Taylor A, Bournas V, Glawe B, Udo MK, Degrado WF, Lamb RA, Pinto LH (2008) Identification of the pore-lining residues of the BM2 ion channel protein of influenza B virus. J Biol Chem 283:15921–15931PubMedCrossRef Ma C, Soto CS, Ohigashi Y, Taylor A, Bournas V, Glawe B, Udo MK, Degrado WF, Lamb RA, Pinto LH (2008) Identification of the pore-lining residues of the BM2 ion channel protein of influenza B virus. J Biol Chem 283:15921–15931PubMedCrossRef
20.
go back to reference Martin K, Helenius A (1991) Nuclear transport of influenza virus ribonucleoproteins: the viral matrix protein (M1) promotes export and inhibits import. Cell 67:117–130PubMedCrossRef Martin K, Helenius A (1991) Nuclear transport of influenza virus ribonucleoproteins: the viral matrix protein (M1) promotes export and inhibits import. Cell 67:117–130PubMedCrossRef
21.
go back to reference Mould JA, Drury JE, Frings SM, Kaupp UB, Pekosz A, Lamb RA, Pinto LH (2000) Permeation and activation of the M2 ion channel of influenza A virus. J Biol Chem 275:31038–31050PubMedCrossRef Mould JA, Drury JE, Frings SM, Kaupp UB, Pekosz A, Lamb RA, Pinto LH (2000) Permeation and activation of the M2 ion channel of influenza A virus. J Biol Chem 275:31038–31050PubMedCrossRef
22.
go back to reference Mould JA, Paterson RG, Takeda M, Ohigashi Y, Venkataraman P, Lamb RA, Pinto LH (2003) Influenza B virus BM2 protein has an ion channel activity that conducts protons across membranes. Dev Cell 5:175–184PubMedCrossRef Mould JA, Paterson RG, Takeda M, Ohigashi Y, Venkataraman P, Lamb RA, Pinto LH (2003) Influenza B virus BM2 protein has an ion channel activity that conducts protons across membranes. Dev Cell 5:175–184PubMedCrossRef
23.
go back to reference Ohuchi M, Cramer A, Vey M, Ohuchi R, Garden W, Klenk H-D (1994) Rescue of vector-expressed fowl plague virus hemagglutinin in biologically active form by acidotropic agents and coexpressed M2 protein. J Virol 68:920–926PubMed Ohuchi M, Cramer A, Vey M, Ohuchi R, Garden W, Klenk H-D (1994) Rescue of vector-expressed fowl plague virus hemagglutinin in biologically active form by acidotropic agents and coexpressed M2 protein. J Virol 68:920–926PubMed
24.
go back to reference Okada A, Miura T, Takeuchi H (2001) Protonation of histidine and histidine–tryptophan interaction in the activation of the M2 ion channel from influenza a virus. Biochemistry 40:6053–6060PubMedCrossRef Okada A, Miura T, Takeuchi H (2001) Protonation of histidine and histidine–tryptophan interaction in the activation of the M2 ion channel from influenza a virus. Biochemistry 40:6053–6060PubMedCrossRef
25.
go back to reference Pinto LH, Holsinger LJ, Lamb RA (1992) Influenza A virus M2 protein has an ion channel activity. Cell 69:517–528PubMedCrossRef Pinto LH, Holsinger LJ, Lamb RA (1992) Influenza A virus M2 protein has an ion channel activity. Cell 69:517–528PubMedCrossRef
26.
go back to reference Pinto LH, Dieckmann GR, Gandhi CS, Papworth CG, Braman J, Shaughnessy MA, Lear JD, Lamb RA, DeGrado WF (1997) A functionally defined model for the M2 proton channel of influenza A virus suggests a mechanism for its ion selectivity. Proc Natl Acad Sci USA 94:11301–11306PubMedCrossRef Pinto LH, Dieckmann GR, Gandhi CS, Papworth CG, Braman J, Shaughnessy MA, Lear JD, Lamb RA, DeGrado WF (1997) A functionally defined model for the M2 proton channel of influenza A virus suggests a mechanism for its ion selectivity. Proc Natl Acad Sci USA 94:11301–11306PubMedCrossRef
27.
go back to reference Sakaguchi T, Leser GP, Lamb RA (1996) The ion channel activity of the influenza virus M2 protein affects transport through the Golgi apparatus. J Cell Biol 133:733–747PubMedCrossRef Sakaguchi T, Leser GP, Lamb RA (1996) The ion channel activity of the influenza virus M2 protein affects transport through the Golgi apparatus. J Cell Biol 133:733–747PubMedCrossRef
28.
go back to reference Sugrue RJ, Hay AJ (1991) Structural characteristics of the M2 protein of influenza A viruses: evidence that it forms a tetrameric channel. Virology 180:617–624PubMedCrossRef Sugrue RJ, Hay AJ (1991) Structural characteristics of the M2 protein of influenza A viruses: evidence that it forms a tetrameric channel. Virology 180:617–624PubMedCrossRef
29.
go back to reference Sugrue RJ, Bahadur G, Zambon MC, Hall-Smith M, Douglas AR, Hay AJ (1990) Specific structural alteration of the influenza haemagglutinin by amantadine. EMBO J 9:3469–3476PubMed Sugrue RJ, Bahadur G, Zambon MC, Hall-Smith M, Douglas AR, Hay AJ (1990) Specific structural alteration of the influenza haemagglutinin by amantadine. EMBO J 9:3469–3476PubMed
30.
go back to reference Tang Y, Zaitseva F, Lamb RA, Pinto LH (2002) The gate of the influenza virus M2 proton channel is formed by a single tryptophan residue. J Biol Chem 277:39880–39886PubMedCrossRef Tang Y, Zaitseva F, Lamb RA, Pinto LH (2002) The gate of the influenza virus M2 proton channel is formed by a single tryptophan residue. J Biol Chem 277:39880–39886PubMedCrossRef
31.
go back to reference Wang C, Lamb RA, Pinto LH (1995) Activation of the M2 ion channel of influenza virus: a role for the transmembrane domain histidine residue. Biophys J 69:1363–1371PubMedCrossRef Wang C, Lamb RA, Pinto LH (1995) Activation of the M2 ion channel of influenza virus: a role for the transmembrane domain histidine residue. Biophys J 69:1363–1371PubMedCrossRef
Metadata
Title
Comparison of the activities of BM2 protein and its H19 and W23 mutants of influenza B virus with activities of M2 protein and its H37 and W41 mutants of influenza A virus
Authors
Tatiana Betakova
Alan J. Hay
Publication date
01-10-2009
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 10/2009
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-009-0483-9

Other articles of this Issue 10/2009

Archives of Virology 10/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.